These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

697 related articles for article (PubMed ID: 28699533)

  • 1. Class A GPCRs: Structure, Function, Modeling and Structure-based Ligand Design.
    Cong X; Topin J; Golebiowski J
    Curr Pharm Des; 2017 Nov; 23(29):4390-4409. PubMed ID: 28699533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GPCR structures in drug design, emerging opportunities with new structures.
    Tautermann CS
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4073-9. PubMed ID: 25086683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. X-ray structure breakthroughs in the GPCR transmembrane region.
    Topiol S; Sabio M
    Biochem Pharmacol; 2009 Jul; 78(1):11-20. PubMed ID: 19447219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure versus function-The impact of computational methods on the discovery of specific GPCR-ligands.
    Bermudez M; Wolber G
    Bioorg Med Chem; 2015 Jul; 23(14):3907-12. PubMed ID: 25828056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing Class A GPCRs to bitter taste receptors: Structural motifs, ligand interactions and agonist-to-antagonist ratios.
    Di Pizio A; Levit A; Slutzki M; Behrens M; Karaman R; Niv MY
    Methods Cell Biol; 2016; 132():401-27. PubMed ID: 26928553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficiency of Homology Modeling Assisted Molecular Docking in G-protein Coupled Receptors.
    Bhunia SS; Saxena AK
    Curr Top Med Chem; 2021; 21(4):269-294. PubMed ID: 32901584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural insights into ligand recognition and selectivity for classes A, B, and C GPCRs.
    Lee SM; Booe JM; Pioszak AA
    Eur J Pharmacol; 2015 Sep; 763(Pt B):196-205. PubMed ID: 25981303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GPCR crystal structures: Medicinal chemistry in the pocket.
    Shonberg J; Kling RC; Gmeiner P; Löber S
    Bioorg Med Chem; 2015 Jul; 23(14):3880-906. PubMed ID: 25638496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in Computational Techniques to Study GPCR-Ligand Recognition.
    Ciancetta A; Sabbadin D; Federico S; Spalluto G; Moro S
    Trends Pharmacol Sci; 2015 Dec; 36(12):878-890. PubMed ID: 26538318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical Diversity in the G Protein-Coupled Receptor Superfamily.
    Vass M; Kooistra AJ; Yang D; Stevens RC; Wang MW; de Graaf C
    Trends Pharmacol Sci; 2018 May; 39(5):494-512. PubMed ID: 29576399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent Advances in Structure-Based Drug Design Targeting Class A G Protein-Coupled Receptors Utilizing Crystal Structures and Computational Simulations.
    Lee Y; Basith S; Choi S
    J Med Chem; 2018 Jan; 61(1):1-46. PubMed ID: 28657745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GPCR Homology Model Generation for Lead Optimization.
    Tautermann CS
    Methods Mol Biol; 2018; 1705():115-131. PubMed ID: 29188560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving virtual screening of G protein-coupled receptors via ligand-directed modeling.
    Coudrat T; Simms J; Christopoulos A; Wootten D; Sexton PM
    PLoS Comput Biol; 2017 Nov; 13(11):e1005819. PubMed ID: 29131821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of Ligand Binding to GPCRs Through Computational Methods.
    Vasile S; Esguerra M; Jespers W; Oliveira A; Sallander J; Åqvist J; Gutiérrez-de-Terán H
    Methods Mol Biol; 2018; 1705():23-44. PubMed ID: 29188557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current and Future Challenges in GPCR Drug Discovery.
    Topiol S
    Methods Mol Biol; 2018; 1705():1-21. PubMed ID: 29188556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational approaches for ligand discovery and design in class-A G protein- coupled receptors.
    Rodríguez D; Gutiérrez-de-Terán H
    Curr Pharm Des; 2013; 19(12):2216-36. PubMed ID: 23016842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breakthrough in GPCR Crystallography and Its Impact on Computer-Aided Drug Design.
    Ciancetta A; Jacobson KA
    Methods Mol Biol; 2018; 1705():45-72. PubMed ID: 29188558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applying Structure-Based Drug Design Approaches to Allosteric Modulators of GPCRs.
    Congreve M; Oswald C; Marshall FH
    Trends Pharmacol Sci; 2017 Sep; 38(9):837-847. PubMed ID: 28648526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relevance of rhodopsin studies for GPCR activation.
    Deupi X
    Biochim Biophys Acta; 2014 May; 1837(5):674-82. PubMed ID: 24041646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fitting the complexity of GPCRs modulation into simple hypotheses of ligand design.
    Custodi C; Nuti R; Oprea TI; Macchiarulo A
    J Mol Graph Model; 2012 Sep; 38():70-81. PubMed ID: 23079642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.